Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program-Reference-Cited by-同舟云学术

Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program

Published:2018-04-03 Issue:2 Volume:39 Page:167-172
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Bachhuber Marcus A.¹,Thompson Cole²,Prybylowski Ann²,Benitez José³,Mazzella Silvana³,Barclay David³

Affiliation:

1. Division of General Internal Medicine, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA

2. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;

3. Prevention Point Philadelphia, Philadelphia, Pennsylvania, USA

Funder

Corporal Michael J. Crescenz Veterans Affairs Medical Center

Robert Wood Johnson Foundation Clinical Scholars Program

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/08897077.2018.1443541

Reference35 articles.

1. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians

2. National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mobile Overdose Response Program: A mobile, low-threshold opioid use disorder treatment model in Philadelphia;Journal of Substance Use and Addiction Treatment;2024-09

2. Patient experiences of buprenorphine dispensing from a mobile medical unit;Addiction Science & Clinical Practice;2024-07-18

3. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care;Harm Reduction Journal;2024-06-01

4. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study;Harm Reduction Journal;2024-03-26

5. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services;Addiction Science & Clinical Practice;2024-03-25